JO
CLSD

John Overdeck’s Clearside Biomedical CLSD Stock Holding History

John Overdeck’s Portfolio CLSD Stock Details CLSD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,978
Closed -$33.2K – 2978
2023
Q2 		$33.2K Sell
1,978
-989
-33% -$17K ﹤0.01% 2869
2023
Q1 		$46.3K Sell
2,967
-3,755
-56% -$72.9K ﹤0.01% 2770
2022
Q4 		$113K Sell
6,722
-4,492
-40% -$80.9K ﹤0.01% 2493
2022
Q3 		$190K Sell
11,214
-2,912
-21% -$63.8K ﹤0.01% 2118
2022
Q2 		$311K Sell
14,126
-8,174
-37% -$198K ﹤0.01% 2014
2022
Q1 		$766K Sell
22,300
-40,387
-64% -$1.21M ﹤0.01% 1816
2021
Q4 		$2.59M Buy
62,687
+7,520
+14% +$487K 0.01% 1703
2021
Q3 		$4.96M Sell
55,167
-17,198
-24% -$1.52M 0.01% 1230
2021
Q2 		$5.29M Buy
72,365
+24,218
+50% +$1.13M 0.01% 1166
2021
Q1 		$1.78M Buy
48,147
+38,198
+384% +$1.92M ﹤0.01% 1799
2020
Q4 		$409K Sell
9,949
-4,101
-29% -$106K ﹤0.01% 2642
2020
Q3 		$325K Buy
14,050
+5,834
+71% +$151K ﹤0.01% 2537
2020
Q2 		$232K Buy
+8,216
New +$242K ﹤0.01% 2545
2019
Q3 		– Sell
-4,389
Closed -$64K – 3492
2019
Q2 		$64K Sell
4,389
-81
-2% -$1.45K ﹤0.01% 3233
2019
Q1 		$93K Sell
4,470
-9,407
-68% -$187K ﹤0.01% 2905
2018
Q4 		$223K Buy
13,877
+7,536
+119% +$354K ﹤0.01% 2646
2018
Q3 		$585K Buy
+6,341
New +$754K ﹤0.01% 2342
2018
Q2 		– Sell
-6,933
Closed -$1.12M – 3351
2018
Q1 		$1.12M Buy
+6,933
New +$845K ﹤0.01% 1936

Other funds holding CLSD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $7.71B AUM 4.02% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
First Manhattan
First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

John Overdeck's CLSD Position: Q3 2023 in Review

John Overdeck sold out of Clearside Biomedical (CLSD) in Q3 2023, closing a stake of 1,978 shares — an estimated $33.2K sold.

John Overdeck first reported a position in CLSD in Q1 2018 and held it in 18 quarters. The position peaked at $5.29M in Q2 2021. 45 funds tracked by Wall St. Rank hold CLSD as of Q3 2023.

  • John Overdeck reported no remaining Clearside Biomedical position as of Q3 2023 after selling out during the quarter.
  • John Overdeck sold 1,978 Clearside Biomedical shares in Q3 2023, an estimated $33.2K.
  • John Overdeck first reported a position in Clearside Biomedical in Q1 2018 and held it in 18 quarters.
  • John Overdeck's Clearside Biomedical position peaked at $5.29M in Q2 2021.
  • 45 funds tracked by Wall St. Rank held Clearside Biomedical as of Q3 2023.

Based on Two Sigma Investments's 13F filing for Q3 2023, filed 14 Nov 2023.